Advancing Oncology Clinical Trials for Supportive Cancer Care
At Mprex, we are committed to pioneering clinical research in oncology, focusing on evaluating standardised herbal, ayurvedic extracts, and nutraceuticals as supportive therapies for cancer patients. Our clinical trials are designed to substantiate the efficacy and safety of herbal extracts and bioactive compounds in enhancing quality of life, managing adverse effects, pain management and improving overall well-being during cancer treatment.
Substantial Claims For Your Product
What to Expect from Oncology Clinical Trials
Nutraceuticals, herbal, ayurvedic and dietary supplements, comprising bioactive natural compounds, hold significant promise in oncology as adjunctive therapies. These products provide complementary support by addressing critical concerns such as inflammation, oxidative stress, immune modulation, and metabolic health. By integrating targeted nutraceutical interventions into cancer care, we aim to enhance treatment tolerance, mitigate therapy-related adverse effects, and promote recovery.
Our studies adhere to Good Clinical Practice (GCP) guidelines, ensuring high-quality, evidence-based
substantiation of nutraceutical claims. Through well-structured, placebo-controlled trials, we provide healthcare professionals with validated insights into the role of natural compounds in integrative oncology.
By bridging the gap between traditional cancer therapies and supportive nutraceutical interventions, our research contributes to a holistic approach in cancer care, empowering patients with safer and scientifically backed solutions for enhanced recovery and long-term wellness.